The Research Council of Lithuania (RCL) invites spin-off companies and companies seeking to commercialise their R&D results to apply for the international online training programme “GOW Individually 1.0.”
Participants can choose between two participation options: select pre-acceleration programmes and specialised courses offered by international organisations recommended by RCL, or independently choose training courses tailored to their needs and focused on the development and commercialisation of R&D results.
When selecting training from RCL recommended options, companies can choose programmes and courses offered by:
🔹 Harvard University
🔹 EIT Health
🔹 MIT xPRO
Companies choosing their own training courses can select options that best match their specific needs, taking into account their field of activity, sector, technological maturity, business requirements, or target international markets, such as the United States, Germany, or other international markets.
Key funding conditions:
🔹 Up to EUR 8,600 in funding is available per project.
🔹 Spin-off companies can receive funding covering up to 100% of eligible project costs.
🔹 Companies seeking to commercialise R&D results can receive funding covering up to 80% of eligible project costs.
🔹 Funding is provided on a reimbursement basis.
🔹 The programme is implemented under the de minimis aid.
🔹 One representative per company may participate.
🔹 All training is delivered online.
Applications are open until November 11, 2026, at 4:00 PM (Lithuanian time).
We encourage companies to take advantage of this opportunity to strengthen their expertise, further develop their R&D results, prepare for commercialisation, and expand into international markets.
The Research Council of Lithuania invites applications for the R&D training programme “How to Commercialise Your Technology?”, designed for young and early-stage life sciences and biotechnology companies that have already started commercialising their research results or are ready to begin the process.
The training will be led by Ashley Kalinauskas (USA), founder and CEO of Torigen Pharmaceuticals. She successfully developed a research outcome from the University of Notre Dame into a product used in veterinary clinics across the United States and has raised more than USD 20 million in private investment.
During two practical sessions, participants will learn how to assess the commercial potential of their technology, understand customer and market needs, evaluate technological, clinical, regulatory and commercial risks, plan their market entry strategy, and prepare an investor pitch. By the end of the programme, each team will develop a 3–6-month action plan.
When?
📅 November 3 | 3:00–6:00 PM
📅 November 17 | 3:00–6:00 PM
The training sessions will take place online via Microsoft Teams. Each session will also be followed by a 30-minute individual consultation with a biotechnology expert.
10 companies will be selected to participate, with up to two representatives per company. Participation costs of up to EUR 350 per company will be compensated under the de minimis aid.
Applicants must submit a 3–10-slide pitch deck as part of the registration process. Please send your presentation to [email protected].
👉 Learn more about the programme: https://lmt.lrv.lt/lt/naujienos/mtep-mokymai-kaip-komercializuoti-savo-technologija-cZm/
Ready to take your startup beyond Europe? Africa could be your next big market.
INFOBALT invites Lithuanian tech startups and innovative companies to join a funded business mission to Cape Town, South Africa, on 15-21/22 November 2026, including participation in Africa Tech Festival 2026 (17-19 November).
Bringing together over 13,000 technology leaders, investors, corporate decision-makers and government representatives, Africa Tech Festival is one of the continent's largest technology events.
What's in it for your startup?
• Explore new markets – discover business and expansion opportunities in South Africa and across the African continent.
• Meet potential customers and partners – connect with corporates, investors, technology companies and public-sector decision-makers.
• Expand your network – join an additional networking and B2B event planned as part of the official Africa Tech Festival programme.
• Discover industry opportunities – explore developments in AI, cybersecurity, fintech, telecommunications, data centres, digital transformation and the startup ecosystem.
• Benefit from financial support – participate at a significantly reduced cost.
Participation costs
Total mission package value: EUR 8,489 per company.Your contribution: EUR 3,450.
The package includes return flights to Cape Town, hotel accommodation for one company representative, an Africa Tech Festival pass, participation in the additional networking/B2B event, and organisational and promotional support.
Application deadline: 27 October 2026. With limited preparation time, interested companies are encouraged to express their interest as soon as possible: [email protected], +370 686 52097
Register HERE.
The Nordic Startup Challenge brings together selected startups from Northern Europe and connects them with Hamburg's business and innovation ecosystem. The programme will take place from 22 to 24 March 2027 and includes workshops, networking opportunities, company visits, pitch training and a public pitch event with corporates and investors.
We are currently looking for promising startups and scaleups from the fields of:
• FinTech
• RegTech
• InsurTech
Participating startups benefit from:
• Direct access to Hamburg's innovation ecosystem
• Exposure to corporates, investors and industry decision-makers
• International networking opportunities
• Insights into market entry and growth opportunities in Hamburg
Register HERE.
Cap Vista publishes challenge statements and invites global companies, startups, and academia to submit proposals that could enhance Singapore's national security.
After evaluating the submitted proposals, Cap Vista invites shortlisted participants to pitch their proposals and address any queries from the evaluation panel, which comprises all relevant stakeholders.
Each successful participant is awarded a fully funded trial covering the costs of validating their solution for the identified use case(s). The trial may take the form of proof-of-concepts, experiments, demonstrations, or other reasonable approaches proposed in the submitted application.
Cap Vista aims to award suitable innovators within 60 days of the submission deadline. Awarded providers gain the opportunity to work directly with end users to showcase and validate their solutions for national security applications. If a solution demonstrates strong results and significant potential, Cap Vista seeks to support its rapid scaling and deployment.
Register HERE.